Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

ACG Amends Terms of Gediktepe Royalty Agreement to...

October 3, 2025

Secondary Trading Notice

April 3, 2025

Microbial Mining? Endolith Makes Copper Recovery Breakthrough with...

May 14, 2025

Graphite Resource Expansion Sets Project up as World-Class

August 19, 2025

CNN Fear and Greed Index Plunges to Lowest...

April 12, 2025

Valeura Ranked No. 1 of Canada’s Top Growing...

October 3, 2025

Eby Unveils Northwest BC Mining Plan Amid Backlash...

May 28, 2025

Commencement of Henbury Field Program

September 1, 2025

Investing in Uranium ETFs: 9 Options for Uranium...

May 10, 2025

Bold Ventures to Present at Metals Investor Forum...

May 9, 2025